Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 371

1.

A placebo controlled trial of bupropion for smoking cessation in schizophrenia.

George TP, Vessicchio JC, Termine A, Bregartner TA, Feingold A, Rounsaville BJ, Kosten TR.

Biol Psychiatry. 2002 Jul 1;52(1):53-61.

PMID:
12079730
2.

A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.

Evins AE, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, Freudenreich O, Henderson DC, Schoenfeld DA, Rigotti NA, Goff DC.

J Clin Psychopharmacol. 2007 Aug;27(4):380-6.

PMID:
17632223
3.

A bupropion smoking cessation clinical trial for cancer patients.

Schnoll RA, Martinez E, Tatum KL, Weber DM, Kuzla N, Glass M, Ridge JA, Langer C, Miyamoto C, Wileyto EP, Leone F.

Cancer Causes Control. 2010 Jun;21(6):811-20. doi: 10.1007/s10552-010-9507-8. Epub 2010 Jan 20.

PMID:
20087643
4.

Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis.

Weiner E, Ball MP, Buchholz AS, Gold JM, Evins AE, McMahon RP, Buchanan RW.

J Clin Psychiatry. 2012 Jan;73(1):95-102. doi: 10.4088/JCP.10m06143gre. Epub 2011 Apr 5.

PMID:
21535998
5.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
6.

A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation.

T√łnnesen P, Tonstad S, Hjalmarson A, Lebargy F, Van Spiegel PI, Hider A, Sweet R, Townsend J.

J Intern Med. 2003 Aug;254(2):184-92.

7.

Sustained-release bupropion for hospital-based smoking cessation: a randomized trial.

Simon JA, Duncan C, Huggins J, Solkowitz S, Carmody TP.

Nicotine Tob Res. 2009 Jun;11(6):663-9. doi: 10.1093/ntr/ntp047. Epub 2009 Apr 24.

PMID:
19395688
8.

A comparison of sustained-release bupropion and placebo for smoking cessation.

Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA, Dale LC, Khayrallah MA, Schroeder DR, Glover PN, Sullivan CR, Croghan IT, Sullivan PM.

N Engl J Med. 1997 Oct 23;337(17):1195-202.

9.

A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia.

Evins AE, Mays VK, Rigotti NA, Tisdale T, Cather C, Goff DC.

Nicotine Tob Res. 2001 Nov;3(4):397-403.

PMID:
11694208
10.

Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia.

Evins AE, Deckersbach T, Cather C, Freudenreich O, Culhane MA, Henderson DC, Green MF, Schoenfeld DA, Rigotti NA, Goff DC.

J Clin Psychiatry. 2005 Sep;66(9):1184-90.

PMID:
16187778
11.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
12.

Two-year follow-up of a smoking cessation trial in patients with schizophrenia: increased rates of smoking cessation and reduction.

Evins AE, Cather C, Rigotti NA, Freudenreich O, Henderson DC, Olm-Shipman CM, Goff DC.

J Clin Psychiatry. 2004 Mar;65(3):307-11; quiz 452-3.

PMID:
15096068
13.

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, Smith SS, Muramoto ML, Daughton DM, Doan K, Fiore MC, Baker TB.

N Engl J Med. 1999 Mar 4;340(9):685-91.

14.

[Bupropion SR for weaning from smoking in relapsed smokers: results of an open multicentre trial in Germany].

Bergmann L, Warncke W, Herschel M.

Pneumologie. 2004 Mar;58(3):140-6. German.

PMID:
15007784
15.

Bupropion for smoking cessation: a randomized trial.

Simon JA, Duncan C, Carmody TP, Hudes ES.

Arch Intern Med. 2004 Sep 13;164(16):1797-803.

PMID:
15364675
16.

Outcomes from an outpatient smoking-cessation clinic.

Roth MT, Andrus MR, Westman EC.

Pharmacotherapy. 2005 Feb;25(2):279-88.

PMID:
15767242
17.

Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo.

Jamerson BD, Nides M, Jorenby DE, Donahue R, Garrett P, Johnston JA, Fiore MC, Rennard SI, Leischow SJ.

Clin Ther. 2001 May;23(5):744-52.

PMID:
11394732
18.

Interventions for smoking cessation and reduction in individuals with schizophrenia.

Tsoi DT, Porwal M, Webster AC.

Cochrane Database Syst Rev. 2010 Jun 16;(6):CD007253. doi: 10.1002/14651858.CD007253.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;2:CD007253.

PMID:
20556777
19.

A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia.

George TP, Vessicchio JC, Sacco KA, Weinberger AH, Dudas MM, Allen TM, Creeden CL, Potenza MN, Feingold A, Jatlow PI.

Biol Psychiatry. 2008 Jun 1;63(11):1092-6. Epub 2007 Dec 21.

20.

Efficacy and safety of bupropion for smoking cessation and reduction in schizophrenia: systematic review and meta-analysis.

Tsoi DT, Porwal M, Webster AC.

Br J Psychiatry. 2010 May;196(5):346-53. doi: 10.1192/bjp.bp.109.066019. Review.

Supplemental Content

Support Center